Return to site

Immuno-oncology Research Services

Explore our genomics service capabilities

Download our Immuno-oncology Research Services Guide

Eremid® is a leading provider of immuno-oncology research services based at the North Carolina Research Campus, Metro-Charlotte, NC.

Immunotherapy is a highly promising but complex area of research in the fight against cancer. Our specialist team and world-leading facilities enable a genomics approach to help researchers maximize the depth of their studies.

Complete the form to download our Immuno-oncology Research Services Guide and request a call with our experts to discuss your needs.

Our commitment to you includes:

  • Expert consultancy on the best way to undertake the research
  • Explaining timelines and level of investment
  • Providing regular, proactive updates on the status of your project

Born out of a long history of providing ground-breaking research and development solutions to academic, government, and industry scientists, we combine the expertise and instrumentation to accelerate your R&D.

We help researchers working in the fields of Human Health, Food & Nutrition, and AgBiotech, to analyze, visualize and interpret data.

Get more from your immuno-oncology research with our genomics approach:

  • Expertise across multiple technologies, including genome sequencing, gene expression analysis, and variant calling
  • High quality analysis and support to investigate a range of processes




    Looking for deeper insights on your next project? Discuss a project
    "Eremid provides the support we need to make a global impact in our large immunogenomic oncology clinical studies. The team’s expertise and flexibility from assay design to data delivery is helping us achieve our vision – an ideal research partner." Geoffrey Erickson, Immunis AI, MI USA — Senior Vice President, Corporate Development
    "Working with Eremid has been a pleasure. We received excellent data with a very fast turnaround and appreciated the attentive and helpful project management!" Steve Watkins, BCD Biosciences, CA USA — CEO
    Trusted by